Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.
- DOI
- 10.1016/s0140-6736(26)00463-0
- Published
- 2026 May 9
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-00463-0,
title = {Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.},
author = {Morand EF and Dall'Era M and Sanchez-Guerrero J and Pearson DR and Werth VP and Wenzel J and Roy S and Kleinmond C and Gühring H and Sgouroudi E and Klopp-Schulze L and Moreau F and Fernandez-Ruiz R and Furie R},
year = {2026},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(26)00463-0},
url = {https://doi.org/10.1016/s0140-6736(26)00463-0}
}RIS
TY - JOUR TI - Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial. AU - Morand EF AU - Dall'Era M AU - Sanchez-Guerrero J AU - Pearson DR AU - Werth VP AU - Wenzel J AU - Roy S AU - Kleinmond C AU - Gühring H AU - Sgouroudi E AU - Klopp-Schulze L AU - Moreau F AU - Fernandez-Ruiz R AU - Furie R PY - 2026 JO - Lancet (London, England) DO - 10.1016/s0140-6736(26)00463-0 UR - https://doi.org/10.1016/s0140-6736(26)00463-0 ER -
APA
EF, M., M, D., J, S., DR, P., VP, W., J, W., S, R., C, K., H, G., E, S., L, K., F, M., R, F., & R, F. (2026). Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)00463-0
Source records
- pubmed · retrieved 2026-09-25T19:29:21.169Z